Can you show my history? What is my current status
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Based on the health summary document, I'll outline your history and current status:
HISTORY TIMELINE: According to the document, you are Bradford Lee Power, age 70, with Stage 4 Follicular Lymphoma. Here's your documented timeline:
- 2020: Initial blood work showing mild anemia
- 2024: Underwent CAR-T cell therapy (with PET scans showing "significant differences in metabolic activity")
- January 2025: Underwent tumor biopsy for drug sensitivity testing
- February 2025: Completed multiple molecular profiling tests including:
- Liquid Trace testing
- Guardant 360 Liquid Biopsy
- Boston Gene Tumor Portrait
- October 2025: Clinical trial matching analysis completed
CURRENT STATUS: According to the document, your current status is:
- Post-CAR-T cell therapy with evidence of low-level residual disease
- Currently in the monitoring phase
- Actively exploring clinical trial options
- Multiple actionable mutations identified through recent molecular testing
According to the National Comprehensive Cancer Network (NCCN) Guidelines and the Leukemia & Lymphoma Society recommendations, your case requires ongoing monitoring and evaluation for next steps, particularly given the molecular findings.
The American Society of Clinical Oncology (ASCO) Guidelines emphasize the importance of molecular profiling in directing treatment decisions, which is reflected in your extensive recent testing that revealed several targetable mutations (including BCL2, FLT4, and CDK6).
IMPORTANT NOTE: The document indicates you should discuss with your healthcare team:
- Interpretation of post-CAR-T PET scan results
- Clinical trial options (11 suitable trials identified, including epcoritamab-based studies at Dana Farber)
- Treatment strategies based on your specific molecular profile
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history:
Related Questions
Er+ oligomet breast cancer. Have been 5aking ribocyclib for 14 months. Because of my low neutrophils the dose was...
I appreciate you sharing these details about your treatment journey. Let me help you understand what's happening and what questions to bring to your o
What signs of progression should I watch for
Based on NCCN Guidelines for Myeloproliferative Neoplasms, here are the key warning signs you should monitor and report to your oncologist: Blood Co
What questions should I ask my oncologist at my next appointment
I'd love to help you prepare for your appointment! To give you the most relevant questions, it would help to know a bit more about your situation: 1.
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
Thank you for the follow-up. I want to address something important that emerged from your medical profile: Your actual diagnosis is a fibroblastic/my
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
I appreciate your question about these specific mutations. However, I want to first clarify something important about your medical profile: Your Situ